Systemic complications of the bidirectional intraoperative chemotherapy with intravenous ifosfamide and hyperthermic intraperitoneal chemotherapy (HIPEC) using cisplatin plus doxorubicin

BACKGROUND: Ifosfamide has recently used as the intravenous component of bidirectional intraoperative chemotherapy (BDIC) with hyperthermic intraperitoneal chemotherapy (HIPEC) using cisplatin plus doxorubicin. Little is known about the systemic toxicities of this BDIC regimen. Therefore, this study...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Pleura Peritoneum
Main Authors: Hakeam, Hakeam, Ayman, Azzam, Waleed, Al Taweel, Amen, Tarek
Formato: Artigo
Idioma:Inglês
Publicado: De Gruyter 2019
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6881663/
https://ncbi.nlm.nih.gov/pubmed/31799375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/pp-2019-0025
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares